AVTX vs PG · P/E 0.0, rev $441.0K vs P/E 25, rev $84.28B
Avalo Therapeutics Inc (AVTX) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported AVTX revenue for 2024-12-31 was $441.0K. Net income was -$35.1M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the AVTX and PG stock pages for the full models.
Not investment advice.